Skip to content

T2 ALPHA 2335-1238SRecalls & reported problems

Stryker GmbH · Femoral Nail PF, LEFT · Class 2 · Implant

All models of T2 ALPHA (123)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613327284881), received between Sep 15, 2020 and Sep 15, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Impaired Healing1
  • Nonunion/Delayed-union Bone Fracture1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 15, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE MANUFACTURER BECAME AWARE OF A POST MARKET CLINICAL FOLLOW-UP REPORT RECEIVED FROM (B)(6), IN USA. THE TITLE OF THIS REPORT IS ¿A RETROSPECTIVE DATA COLLECTION OF THE TREATMENT OF FEMORAL FRACTURES WITH THE FEMORAL NAIL PIRIFORMIS FOSSA (PF) OF THE T2 ALPHA FEMUR ANTEGRADE GT/PF NAILING SYSTEM¿ WHICH IS ASSOCIATED WITH THE STRYKER ¿T2 ALPHA FEMUR ANTEGRADE GT/PF NAILING SYSTEM¿. THIS STUDY INCLUDES RESEARCH DONE ON 18 PATIENTS (19 CASES) REQUIRING SURGERY BETWEEN THE PERIOD MARCH 2019 AND OCTOBER 2019. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE DETAILS FROM THE REPORT, OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED COMPLAINTS. THEREFORE, NEW COMPLAINT WAS INITIATED IN THE SYSTEM FOR THE POST-OPERATIVE COMPLICATION MENTIONED IN THE REPORT. THIS PRODUCT INQUIRY ADDRESSES DELAYED UNION. THE REPORT STATES: ¿THE 2ND PATIENT WITH DELAYED UNION OCCURRED 105 DAYS AFTER THE INITIAL SURGERY, IS ONGOING, AND A LOW POWER ELECTROMAGNETIC OSTEOGENIC STIMULATOR DEVICE WAS PRESCRIBED. THE PATIENT IS A (B)(6) YEARS OLD FEMALE, SMOKER, DIABETIC, AND HAS A HISTORY OF HYPOTHYROIDISM, AND RHEUMATOID ARTHRITIS. SHE HAD A STANDING FALL, AND SHE WAS ADMITTED TO THE HOSPITAL WITH A CLOS

    Patient problems: Impaired Healing; Nonunion/Delayed-union Bone Fracture

    MAUDE report 10538483 ↗

Other Screw, fixation, bone devices

All Screw, fixation, bone devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page